Cite

    Xu, J., Xu, R., Qin, S., Pan, H., Bai, Y., Chi, Y., Wang, L., Bi, F., Cheng, Y., Liu, T., Ma, D., Shen, L., Ba, Y., Liang, J., Wang, X., Yau, T. C. C., Ma, B. B., Yeh, K., Lin, J., Kappeler, C., Shapiro, J., Kalmus, J., & Li, J. (2020). regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial. Journal of gastroenterology and hepatology, 35(8), 1307–1316. http://access.bl.uk/ark:/81055/vdc_100105877403.0x000044